Phoenix Life Sciences International Limited
PLSI · OTC
2/28/2019 | 11/30/2018 | 8/31/2018 | 5/31/2018 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $2 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $2 | -$2 | -$0 | $0 |
| Operating Expenses | $1 | $2 | -$0 | $0 |
| Operating Income | -$1 | -$2 | -$0 | -$0 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $2 | -$1 | -$0 | -$0 |
| Pre-Tax Income | $0 | -$3 | -$0 | -$0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $0 | -$3 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EPS | 5.87 | -82.56 | -6.19 | -4.01 |
| % Growth | 107.1% | -1,233.8% | -54.4% | – |
| EPS Diluted | 5.87 | -82.56 | -8.4 | -4.01 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $2 |
| EBITDA | $0 | -$3 | -$0 | -$0 |
| % Margin | – | – | – | – |